Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Stratasys
SSYS
$666M
| $145K | ﹤0.01% |
17,308
+1,449
| +9% | +$13.8K |
|
|
BBBY
3877
Bed Bath & Beyond
BBBY
$479M
| $144K | ﹤0.01% |
12,119
+1,127
| +10% | +$20K |
|
3878
NerdWallet
NRDS
$632M
| $144K | ﹤0.01% |
9,840
+4,262
| +76% | +$58.4K |
|
3879
NextNav
NN
$1.79B
| $143K | ﹤0.01% |
17,647
+7,921
| +81% | +$62.6K |
|
|
CTO
3880
CTO Realty Growth
CTO
$756M
| $143K | ﹤0.01% |
8,193
+2,234
| +37% | +$38.7K |
|
|
TBCH
3881
Turtle Beach Corp
TBCH
$238M
| $142K | ﹤0.01% |
9,928
+888
| +10% | +$13.8K |
|
3882
Acco Brands
ACCO
$399M
| $142K | ﹤0.01% |
30,231
-62,322
| -67% | -$311K |
|
3883
iShares MSCI Intl Value Factor ETF
IVLU
$4.32B
| $142K | ﹤0.01% |
+5,157
| New | +$145K |
|
3884
Fulcrum Therapeutics
FULC
$241M
| $141K | ﹤0.01% |
22,791
-155,773
| -87% | -$1.18M |
|
3885
Ring Energy
REI
$307M
| $141K | ﹤0.01% |
83,427
+11,772
| +16% | +$21.6K |
|
3886
NETGEAR
NTGR
$612M
| $141K | ﹤0.01% |
9,209
+614
| +7% | +$8.59K |
|
3887
C4 Therapeutics
CCCC
$389M
| $141K | ﹤0.01% |
30,456
-740,272
| -96% | -$4.41M |
|
|
SLRN
3888
DELISTED
ACELYRIN
SLRN
| $141K | ﹤0.01% |
31,884
+18,628
| +141% | +$87.3K |
|
3889
Karyopharm Therapeutics
KPTI
$155M
| $141K | ﹤0.01% |
10,802
+9,540
| +756% | +$158K |
|
3890
SmartFinancial
SMBK
$906M
| $141K | ﹤0.01% |
5,938
+2,567
| +76% | +$55.5K |
|
3891
FlexShares Quality Dividend Defensive Index Fund
QDEF
$545M
| $140K | ﹤0.01% |
2,138
| – | – |
|
3892
UroGen Pharma
URGN
$1.97B
| $140K | ﹤0.01% |
8,332
+3,494
| +72% | +$49.7K |
|
3893
VanEck Uranium + Nuclear Energy ETF
NLR
$3.67B
| $139K | ﹤0.01% |
1,744
+108
| +7% | +$8.81K |
|
|
SEI
3894
Solaris Energy Infrastructure
SEI
$2.66B
| $139K | ﹤0.01% |
16,253
+8,897
| +121% | +$77.8K |
|
3895
Republic Bancorp
RBCAA
$1.96B
| $139K | ﹤0.01% |
2,595
+339
| +15% | +$17.3K |
|
|
GOOD
3896
Gladstone Commercial Corp
GOOD
$623M
| $139K | ﹤0.01% |
9,722
+1,812
| +23% | +$25.2K |
|
3897
FuelCell Energy
FCEL
$1.45B
| $139K | ﹤0.01% |
7,238
-6,661
| -48% | -$179K |
|
3898
Nomura Holdings
NMR
$28.3B
| $138K | ﹤0.01% |
23,925
+1,450
| +6% | +$8.59K |
|
3899
Universal Technical Institute
UTI
$2.26B
| $138K | ﹤0.01% |
8,771
-816
| -9% | -$12.2K |
|
3900
Daily Journal
DJCO
$826M
| $137K | ﹤0.01% |
348
+58
| +20% | +$21.3K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.